Skip to content
The Nexus
DossierENTITY

Alex Zhavoronkov

Coverage of Alex Zhavoronkov in the Nexus archive.

Earliest in view: Jun 22 · 21:00 UTCMost recent: Jul 28 · 11:07 UTC
Co-mentioned in this coverage
Insilico Medicineorganization2Abu Dhabiplace1M42organization1UAEplace1AI computing powertopic1GLP-1 drugstopic1SK Biopharmaceuticalsorganization1Pharma.AItopic1neuroimmune therapiestopic1Donghoon Leeperson1SK Grouporganization1Eli Lillyorganization1
Recent coverage
  • HEALTHJul 28 · 11:07 UTCSEMAFOR
    Abu Dhabi lab advances AI search for non-opioid painkillers

    Insilico Medicine, a biotech firm, leverages Abu Dhabi's AI computing resources to develop a non-opioid painkiller candidate, its second from the UAE facility. The drug, nearing human trials, could revolutionize pain treatment and is part of Abu Dhabi's broader strategy to attract biotech innovation through investments and infrastructure.

  • BUSINESSJun 22 · 21:00 UTCFORTUNE
    Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies

    Insilico Medicine and SK Biopharmaceuticals signed a $2.5B partnership to develop neuroimmune therapies using AI-driven drug discovery. Insilico will design candidates via its Pharma.AI platform, while SK Biopharmaceuticals handles late-stage development and commercialization. The deal includes potential milestone payments and royalties, marking Insilico's largest Asia-Pacific collaboration.